Skin lesions associated with new coronavirus infection (COVID-19)


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The review provides detailed descriptions of the various rashes associated with the new coronavirus infection (COVID-19) that occur in patients with laboratory-confirmed disease, and also analyzes the diagnostic value of the rashes. The features of immunosuppressive therapy of severe chronic dermatoses against the background of coronavirus infection are described. The approaches to neutralizing the negative effects of the constant use of personal protective equipment on the skin and the experience of organizing a dermatological service against the background of the COVID-19 pandemic are summarized.

Full Text

Restricted Access

About the authors

I. V Kosheleva

Russian Medical Academy of Continuous Professional Education; AO Russian Railways-Health

O. A Bitkina

Privolzhsky Research Medical University

Email: oksana381@yandex.ru
Dr. Sci. (Med.), Professor, Department of Skin and Sexually Transmitted Diseases

L. I Shadyzheva

Russian Medical Academy of Continuous Professional Education

A. Yu Nikolaeva

Privolzhsky Research Medical University

O. V Andriyakhina

AO Russian Railways-Health

O. A Pankova

Privolzhsky Research Medical University

E. S Udalova

Privolzhsky Research Medical University

A. A Tsyganova

Privolzhsky Research Medical University

References

  1. Gupta G., Singh Y, Chellappan D.K., Dua K New Emerging Dermatological Symptoms in Coronavirus Pandemic. J Cosmet Dermatol. 2020. PMID: 32365277. doi: 10.1111/jocd.13466.
  2. Kalner S., Vergilis I.J. Periorbital Erythema as a Presenting Sign of Covid-19. JAAD Case Rep. 2020. PMID: 32395600; PMCID: PMC7212975. doi: 10.1016/j.jdcr.2020.05.001.
  3. Castelnovo L., Capelli F, Tamburello A., et al. Symmetric Cutaneous Vasculitis in COVID-19 Pneumonia» J Eur Acad Dermatol. Venereol. 2020;PMID: 32378747. doi: 10.1111/jdv.16589
  4. Vanegas Ramirez A., Efe D., Fischer M. Drug-induced Vasculitis in a Patient With COVID-19. J Eur Acad Dermatol Venereol. 2020. PMID: 32378770. doi: 10.1111/jdv.16588.
  5. Marzano A.V, Genovese G., Fabbrocini G., et al. Varicella-like Exanthem as a Specific COVID-19-associated Skin Manifestation: Multicenter Case Series of 22 Patients. J Am Acad Dermatol. 2020;S0190-9622(20)30657-5. PMID: 32305439. doi: 10.1016/j.jaad.2020.04.044,
  6. Ortega-Quijano D., Jimenez-Cauhe J., Burgos- Blasco P, et al. Reply to «Varicella-like Exanthem as a Specific COVID-19-associated Skin Manifestation: Multicenter Case Series of 22 Patients»: Discussing Specificity. J Am Acad Dermatol. 2020;S0190-9622(20)30778-7. PMID: 32380215; PMCID: PMC7198135. doi: 10.1016/j.jaad.2020.04.156
  7. Fernandez-Nieto D., Ortega-Quijano D., Jimenez-Cauhe J., et al. Clinical and Histological Characterization of Vesicular COVID-19 Rashes: A Prospective Study in a Tertiary Care Hospital. Clin Exp Dermatol. 2020 May 8;10.1111/ced.14277. PMID: 32384180; PMCID: PMC7273083. doi: 10.1111/ced.14277.
  8. Morey-Olive M., Espiau M., Mercadal-Hally M., et al. Cutaneous Manifestations in the Current Pandemic of Coronavirus Infection Disease (COVID 2019)». Pediat (Barc). 2020 Apr 17;S1695-4033(20)30165-X. PMID: 32389502; PMCID: PMC7164857. Doi: 10.1016/j. anpedi.2020.04.013.
  9. De Masson A., Bouaziz J.-D., Sulimovic L., et al. Chilblains Are a Common Cutaneous Finding During the COVID-19 Pandemic: A Retrospective Nationwide Study From France. J Am Acad Dermatol. 2020 May 4;S0190-9622(20)30789-1. PMID: 32380219; PMCID: PMC7198162. doi: 10.1016/j.jaad.2020.04.161.
  10. Suarez-Valle A., Fernandez-Nieto D., Diaz-Guimaraens B. Acro-ischemia in Hospitalized COVID-19 Patients. J Eur Acad Dermatol. Venereol. 2020 May 7;PMID: 32378743. Doi: 10.1111/ jdv. 16592.
  11. Saenz Aguirre A., De la Torre Gomar F.J., Roses-Gibert P., et al. Novel Outbreak of Acral Lesions in Times of COVID-19: A Description of 74 Cases From a Tertiary University Hospital in Spain. Clin Exp Dermatol. 2020 May 18;10.1111/ced.14294. PMID: 32421857; PMCID: PMC7276798. doi: 10.1111/ced.14294.
  12. Piccolo V., Bassi A. Acral Findings During the COVID-19 Outbreak: Chilblain-like Lesions Should Be Preferred to Acro-Ischemic Lesions. J Am Acad Dermatol. 2020May21;S0190-9622(20)30946 4. PMID: 32446827; PMCID: PMC7242179. doi: 10.1016/j.jaad.2020.05.077
  13. Fernandez-Nieto D., Jimenez-Cauhe J., Suarez-Valle A., et al. Comment On: «Acral Findings During the COVID-19 Outbreak: Chilblain-like Lesions Should Be Preferred to Acro-Ischemic Lesions. J Am Acad Dermatol. 2020 May 21;S0190-9622(20)30947-6. PMID: 32446824; PMCID: PMC7241383. doi: 10.1016/j.jaad.2020.05.078.
  14. Rivera-Oyola R., Koschitzky M., Printy R., et al. Dermatologic Findings in Two Patients With COVID-19. JAAD Case Rep. 2020 Apr 28;PMID: 32346588; PMCID: PMC7187826. doi: 10.1016/j.jdcr.2020.04.027.
  15. Cepeda-Valdes R., Carrion-Alvarez D., Trejo-Castro A., et al. Cutaneous Manifestations in COVID-19: Family Cluster of Urticarial Rash. Clin Exp Dermatol. 2020 May 14;PMID: 32407564. Doi: 10.1111/ ced.14290 18.
  16. Janah H., Zinebi A., Elbenaye J. Atypical Erythema Multiforme Palmar Plaques Lesions Due to Sars-Cov-2. J Eur Acad Dermatol Venereol. 2020 May 9;PMID: 32386446. doi: 10.1111/jdv.16623.
  17. De GiorgiV, Recalcati S., Jia Z., et al. Cutaneous Manifestations Related to Coronavirus Disease 2019 (COVID-19): A Prospective Study From China and Italy. J Am Acad Dermatol. 2020 May 19;S0190-9622(20)30941-5. PMID: 32442696; PMCID: PMC7235557. doi: 10.1016/j.jaad.2020.05.073.
  18. Skroza N., Bernardini N., Balduzzi V, et al. A Late Onset Widespread Skin Rash in a Previous Covid-19 Infected Patient: Viral or Multidrug Effect? J Eur Acad Dermatol Venereol. 2020 May 18;10.1111/jdv.16633. PMID: 32421877; PMCID: PMC7276891. doi: 10.1111/jdv.16633.
  19. Wollina U., Serap Karadağ A., Rowland-Payne C., et al. Cutaneous Signs in COVID-19 Patients: A Review. Dermatol Ther. 2020 May 10;e13549; PMID: 32390279. doi: 10.1111/dth.13549.
  20. Duramaz B., Yozgat C.Y., Yozgat Y., et al. Appearance of Skin Rash in Pediatric Patients With COVID-19: Three Case Presentations. Dermatol Ther. 2020 May 15;e13594. PMID: 32412681; PMCID: PMC7261998. doi: 10.1111/dth.13594.
  21. Jia J.L., Kamceva M., Rao S.A., Linos E. Cutaneous Manifestations of COVID-19: A Preliminary Review. J Am Acad Dermatol. 2020 May 15;S0190-9622(20)30924-5. PMID: 32422225; PMCID: PMC7229462. Doi: 10.1016/j. jaad.2020.05.059.
  22. Young S., Fernandez A.P Skin Manifestations of COVID-19. Cleveland Clinic. J Med. 2020 May 14. PMID: 32409442. doi: 10.3949/ccjm.87a.ccc031.
  23. Rudnicka L., Goldust M., Glowacka P, el al. Cyclosporine Therapy During the COVID-19 Pandemic Is Not a Reason for Concern. J Am Acad Dermatol. 2020 May 3;S0190-9622(20)30775 1. PMID: 32376422; PMCID: PMC7196541. doi: 10.1016/j.jaad.2020.04.153
  24. Benhadou F, Del Marmol V Improvement of SARS-CoV2 Symptoms Following Guselkumab Injection in a Psoriatic Patient. J Eur Acad Dermatol Venereol. 2020 May 7;PMID: 32379925. Doi: 10.1111/ jdv.16590
  25. Conti A., lasagni C., Bigi L., Pellacani G. Evolution of COVID-19 Infection in 4 Psoriatic Patients Treated With Biological Drugs. J Eur Acad Dermatol Venereol. 2020 May 7;PMID: 32379913. doi: 10.1111/jdv. 16587
  26. Di Lernia V., Bombonato C., Motolese A. COVID-19 in an Elderly Patient Treated With Secukinumab. Dermatol Ther. 2020 May 13;e13580. PMID: 32406078. doi: 10.1111/dth.13580
  27. Shah M., Sachdeva M., Alavi A., et al. Optimizing Care for Atopic Dermatitis Patients During COVID 19 Pandemic. J Am Acad Dermatol. 2020 May 13;PMID: 32405123; PMCID: PMC7217788. doi: 10.1016/j.jaad.2020.05.027
  28. Ferrucci S., Romagnuolo M., Angileri L., et al. Safety of Dupilumab in Severe Atopic Dermatitis and Infection of Covid-19: Two Case Reports. J Eur Acad Dermatol Venereol. 2020 Apr 24;PMID: 32330323. doi: 10.1111/jdv.16527.
  29. Patruno C., Nisticö S.P, Fabbrocini G., Napolitano M. COVID-19, Quarantine, and Atopic Dermatitis. Med. Hypotheses. 2020 May 19;143:109852. PMID: 32447099; PMCID: PMC7236680. doi: 10.1016/j.mehy. 2020.109852.
  30. Sachdeva M., Mufti A., MaliyarK., et al. Hydroxychloroquine Effects on Psoriasis: A Systematic Review and a Cautionary Note for COVID-19 Treatment. J Am Acad Dermatol. 2020 May 19;S0190-9622(20)30942-7. PMID: 32442699; PMCID: PMC7235574. doi: 10.1016/j.jaad.2020.05.074.
  31. Litaiem N., Hajlaoui K., Karray M., et al. Acute Generalized Exanthematous Pustulosis After COVID-19 Treatment With Hydroxychloroquine. Dermatol. Ther. 2020 May 13;e13565; PMID: 32401410; PMCID: PMC7261985. doi: 10.1111/dth.13565.
  32. Abtahi-Naeini B. Frequent Handwashing Amidst the COVID-19 Outbreak: Prevention of Hand Irritant Contact Dermatitis and Other Considerations. Health Sci Rep. 2020;3(2):e163. PMID: 32346616; PMCID: PMC7185953. doi: 10.1002/hsr2.163.
  33. Maliyar K., Sachdeva M., Mufti A., Yeung J. Reply To: Skin Damage Among Healthcare Workers Managing Coronavirus disease-2019. J Am Acad Dermatol. 2020 May 14;S0190-9622(20)30868-9.
  34. Blicharz L., Czuwara J., Samochocki Z., et al. Hand Eczema - A Growing Dermatological Concern During the COVID-19 Pandemic and Possible Treatments. Dermatol Ther. 2020 May 8;e13545. PMID: 32384196; PMCID: PMC7261986. doi: 10.1111/dth.13545.
  35. Dong L., Yang L., Li Y., et al. Efficacy of Hydrogel Patches in Preventing Facial Skin Damage Caused by Mask Compression in Fighting Against Coronavirus Disease 2019: A Short-Term, Self-Controlled Study. J Eur Acad Dermatol Venereol. 2020 May 18;10.1111/jdv.16638. PMID: 32421878; PMCID: PMC7276886. doi: 10.1111/jdv.16638.
  36. Rismiller K., Cartron A.M., Trinidad J.C.L. Inpatient Teledermatology During the COVID-19 Pandemic. J. Dermatol. Treat. 2020 May 13;1-3. doi: 10.1080/09546634.2020.1762843.
  37. Freeman E.E., McMahon D.E., Fitzgerald M.E., et al. The AAD COVID-19 Registry: Crowdsourcing Dermatology in the Age of COVID-19. J Am Acad Dermatol. 2020 Apr 16;S0190-9622(20)30658-7. PMID: 32305438. Doi: 10.1016/j. jaad.2020.04.045.
  38. Nazzaro G., Marzano A.V, Berti E. What Is the Role of a Dermatologist in the Battle Against COVID-19? The Experience From a Hospital on the Frontline in Milan. Int J Dermatol. 2020 May 7;PMID: 32378731. doi: 10.1111/ijd.14926.
  39. Al-Niaimi F, Ali F.R. COVID-19 and Dermatologic Surgery: Hazards of Surgical Plume. Dermatol Ther. 2020 May 15;e13593. PMID: 32412689; PMCID: PMC7262016. Doi: 10.1111/ dth.13593.
  40. Damevska K., Neloska L., Simeonovski V, et al. Impact of COVID-19 Outbreak on Dermatology Services: Dermatology in Isolation. Dermatol Ther. 2020 May 10;e13552. PMID: 32390176. doi: 10.1111/dth.13552.
  41. Cerro P.A., Palma A.M., Navarro-Bielsa A, et al. RF-Organisation of a Dermatology Department During the COVID-19 Pandemic. Actas Dermosifiliogr. 2020 Apr 24;S0001-7310(20)30106-X. PMID: 32389322; PMCID: PMC7181984. doi: 10.1016/j.ad.2020.04.003.
  42. Loh T.Y., Hsiao J.L., Shi V.Y COVID-19 and Its Impact on Medical Student Education in Dermatology. J Am Acad Dermatol. 2020 May 12;S0190-9622(20)30857-4. PMID: 32413448; PMCID: PMC7252068. doi: 10.1016/j.jaad.2020.05.026.
  43. Muzumdar S., Grant-Kels J.M., Feng H. Dear Dermatoethicist: Web-Based Dermatology Residency Interviews in the Time of COVID-19. J Am Acad Dermatol. 2020 May 12;S0190-9622(20)30856-2. PMID: 32413445; PMCID: PMC7217072. Doi: 10.1016/j. jaad.2020.05.025.
  44. Arora G., Jafferany M., Arora S. Balancing Aesthetic and Conventional Dermatology Practice in the COVID-19 Era. Dermatol Ther. 2020 May 19;e13620. PMID: 32431094. Doi: 10.1111/ dth.13620.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies